Regina Miftakhova
- Oncology top 10%
- CAR-T cell therapy research 7
- Cancer Cells and Metastasis 6
-
- Cancer, Hypoxia, and Metabolism 3
-
- Prostate Cancer Treatment and Research 5
-
- Virus-based gene therapy research 4
-
- Nanowire Synthesis and Applications 4
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
Regina Miftakhova
36 papers receiving 856 citations
Peers
Comparison fields: 5 of 112
- Complementary and Manual Therapy 32
- Oncology 309
- Cancer Research 111
- Immunology 143
- Biomaterials 76
Countries citing papers authored by Regina Miftakhova
This map shows the geographic impact of Regina Miftakhova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regina Miftakhova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regina Miftakhova more than expected).
Fields of papers citing papers by Regina Miftakhova
This network shows the impact of papers produced by Regina Miftakhova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regina Miftakhova. The network helps show where Regina Miftakhova may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Regina Miftakhova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 38 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 54 | |
| 14 | 2018 | 37 | |
| 15 | 2018 | 31 | |
| 16 | 2018 | 49 | |
| 17 | 2016 | 47 | |
| 18 | 2016 | 24 | |
| 19 | 2014 | 19 | |
| 20 | 2013 | 27 |
About Regina Miftakhova
Regina Miftakhova is a scholar working on Oncology, Cancer Research and Aging, having authored 41 papers that have together received 867 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Cancer Cells and Metastasis (6 papers), Prostate Cancer Treatment and Research (5 papers), Virus-based gene therapy research (4 papers), Nanowire Synthesis and Applications (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Complementary and Manual Therapy (32 citations), Oncology (309 citations) and Cancer Research (111 citations). Regina Miftakhova has collaborated with scholars based in Russia, Sweden and United States. Frequent co-authors include Albert A. Rizvanov, Emil Bulatov, Jenny L. Persson, Alexey Petukhov, Ekaterina Zmievskaya, Aygul Valiullina, Aleksei Titov, Nigel P. Mongan, Andreas Hedblom and Irina Ganeeva. Their work appears in journals such as Cancers, International Journal of Molecular Sciences, Oncotarget, Cell Cycle and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.